International Edition
Latest News
Health

J&J to Install First Ottava Robot at Memorial Hermann-Texas Medical Center

Memorial Hermann-Texas Medical Center will install Johnson & Johnson's Ottava surgical system as the first U.S. hospital to use the technology commercially. Johnson & Johnson announced the agreement on Thursday, marking a major milestone in the company's expansion…

J&J to Install First Ottava Robot at Memorial Hermann-Texas Medical Center

Memorial Hermann-Texas Medical Center will install Johnson & Johnson’s Ottava surgical system as the first U.S. hospital to use the technology commercially.

Johnson & Johnson announced the agreement on Thursday, marking a major milestone in the company’s expansion into surgical robotics. Tim Schmid, worldwide chairman for medtech, said in a statement reported by [MedTech Dive] that the commercial placement moves the company toward leading the surgical robotics market.

Surgery remains a large global business for Johnson & Johnson.

The company is mounting a major push into the robotics sector to challenge longtime market leader Intuitive in the United States.

The commercial agreement follows Food and Drug Administration de novo authorization granted in July for the soft tissue robot. The regulatory clearance permits the system’s use in 10 general surgery procedures within the upper abdomen.

The Ottava system features four robotic arms integrated directly into a standard-sized surgical table. This table-integrated design aims to address persistent hospital challenges like operating room space constraints and workflow complexities.

Authorized procedures include Roux-en-Y gastric bypass, gastrectomy, cholecystectomy, splenectomy, and gastric sleeve operations. The FDA clearance also covers small bowel resection, appendectomy, lysis of adhesions, fundoplication, and hiatal hernia repair.

Memorial Hermann served as a clinical trial site during the investigational device exemption program that supported the regulatory submission.

Hani Abouhalka, company group chair of surgery for Johnson & Johnson MedTech, said that the company looks forward to supporting the hospital in generating real-world evidence, according to [MassDevice].

“Today’s milestone is a significant step for Johnson & Johnson as we commercialize Ottava and continue building on our ambition to lead in surgical robotics,” Schmid said in the announcement, as reported by [MassDevice].

“We will work alongside health systems and surgical teams, bringing the breadth of Johnson & Johnson to support expanding access to robotic surgery, improve workflow and procedural efficiencies, and address the evolving needs of care teams,” Johnson & Johnson MedTech EVP and Worldwide Chairman Tim Schmid said.

Johnson & Johnson was founded in 1886 in New Brunswick, New Jersey, by Robert Wood Johnson and his brothers James Wood Johnson and Edward Mead Johnson, starting with 14 employees producing the first mass-manufactured sterile surgical dressings.

The company published the first commercial first-aid manual in 1888, distributing 85,000 copies to promote antiseptic surgery, and introduced the first commercial first-aid kit the same year for railroad workers. It remains one of only two U.S.-based corporations holding a AAA credit rating from S&P Global.

Memorial Hermann installs J&J's Ottava surgical robot — and more news — Robotics News Daily

The deployment coincides with moves from rival medical technology companies in the domestic market. Medtronic recently announced FDA clearance for its Hugo robot in upper abdominal general surgery, expanding its applications beyond urologic procedures such as prostate removal.

Johnson & Johnson plans to continue the commercial rollout of Ottava with select U.S. customers. The company stated it will focus on early customer success while evaluating the platform for additional clinical indications.

About the author: Health Desk

Health Desk at Archynewsy.